Open Medicine
Safety study of sitagliptin combined with metoprolol on the treatment of elderly patients with type 2 diabetes mellitus and hypertension
By Dai Xiaoqing and Yu Jiali.
Abstract
Sitagliptin is a standard therapeutic option for type 2 diabetes mellitus (T2DM), while metoprolol is an antihypertensive agent. This study aimed to assess the safety of their combination therapy in elderly patients with T2DM and hypertension.
Keywords
- type 2 diabetes mellitus
- hypertension
- sitagliptin
- metoprolol
- safety
- Open access
Source
Published in Open Medicine. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
At a glance
- Journal
- Open Medicine
